Skip to main content
. 2021 Jan;10(1):184–194. doi: 10.21037/tcr-20-2772

Figure 4.

Figure 4

Kaplan-Meier plot of PFS in EGFR wild-type oligometastatic NSCLC patients with ECOG performance status <2 or ≥2. ECOG PS, Eastern Cooperative Oncology Group performance status; PFS, progression-free survival; EGFR, epidermal growth factor receptor; NSCLC, non-small cell lung cancer.